StockWatch
·

Piramal Pharma Ltd Q3 FY25 Results

PPLPHARMAQ3 FY25 Results
Filing
MetricValue ( Cr)vs Q2 FY25
Revenue2.2K1.7%
Total Income2.2K3.8%
Expenditure2.2K1.5%
PBT49.7551.6%
Net Profit3.6883.7%
OPM-11.91%0.40pp
NPM-0.60%0.83pp
EPS0.0382.3%
View full financials

Informational and educational content only. Not investment advice.